Potassium binder
Patiromer calcium
Brand names: Veltassa
Adult dose
Dose: Initial 8.4g OD; titrate weekly to max 25.2g OD
Route: PO
Frequency: OD
Clinical pearls
- Chronic hyperkalaemia in CKD/HF on RAASi to enable dose optimisation
- NICE TA1064 supports use
Contraindications
- Bowel obstruction
- Hypersensitivity
Side effects
- Constipation
- Hypomagnesaemia
- Hypocalcaemia (mild)
- Diarrhoea
- Abdominal pain
Interactions
- Many — separate from other oral drugs by ≥3h before or after
- Levothyroxine, ciprofloxacin, metformin, mycophenolate
Monitoring
- K+
- Mg2+
- U&E
Reference: BNF; NICE TA1064; SmPC; https://bnf.nice.org.uk/drugs/patiromer-calcium/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines